The MarketReader Minute
💊 Centessa Surges on $6.3B Eli Lilly Acquisition | Biotech Sector Insights
IBB rose over 4% as biotech rallied on renewed M&A momentum, led by Eli Lilly's agreement to acquire Centessa. Gains across holdings including Apellis, Regeneron, Moderna and Gilead supported the move, reflecting improved sentiment in the sector.